TriSalus Life Sciences, Inc.

MedTech Acquisition Corp, trading under the ticker MTAC, was a blank-check company sponsored by MedTech Acquisition Sponsor LLC that completed its initial public offering in 2021 with a focus on the healthcare and medical technology sector. The SPAC pursued a business combination with TriSalus Life Sciences, Inc., a commercial-stage oncology company specializing in pressure-enabled drug delivery systems for the treatment of liver-dominant tumors. The July 2023 Form 8-K filing with accession number 0001104659-23-078462 reflects activity surrounding the de-SPAC transaction, marking a key milestone in the combined company's transition to a publicly traded operating entity. Sign up at SpacDesk for complete filing history, deal timelines, and institutional-grade data on this and every active SPAC transaction.